{"database":"ecrin-mdr-crc","file_versions":[],"scores":null,"additional":{"omics_type":["Clinical"],"study_start_year":["2022"],"data_sharing_plan":["IPD Sharing (as of April 2022): Yes\nDescription: The Dana-Farber / Harvard Cancer Center encourages and supports the responsible and ethical sharing of data from clinical trials. De-identified participant data from the final research dataset used in the published manuscript may only be shared under the terms of a Data Use Agreement. Requests may be directed to: [contact information for Sponsor Investigator or designee]. The protocol and statistical analysis plan will be made available on Clinicaltrials.gov only as required by federal regulation or as a condition of awards and agreements supporting the research.\nTime frame: Data can be shared no earlier than 1 year following the date of publication\nAccess Criteria: Contact the Partners Innovations team at http://www.partners.org/innovation\nAdditional information available: Study Protocol, Statistical Analysis Plan, Informed Consent Form"],"condition":["Colorectal Cancer","Colorectal Neoplasms","Salicylates"],"disease":["Colorectal Cancer","Colorectal Neoplasms","Salicylates"],"study_type":["Interventional"],"full_dataset_link":["https://newmdr.ecrin.org/Study/2390610"],"location":["United States"],"study_start_month":["3"],"keyword":["Aspirin","Salicylic Acid"],"repository":["ECRIN MDR"],"study_status":["Recruiting"],"additional_accession":[]},"is_claimable":false,"name":"ASPIRED-XT: ASPirin Intervention for the REDuction of Colorectal Cancer Risk -EXTension","description":"This research study is studying a drug intervention as a possible chemoprevention strategy for colorectal cancer.\nThe name of the study intervention involved in this study is:\n* Low Dose Aspirin","dates":{"creation":"2022-03-15"},"accession":"2390610","cross_references":{"ClinicalTrials___gov":["NCT05056896"]}}